evidence: The MHRA closely monitors the safety of COVID-19 vaccine exposures in pregnancy, including published information as well as Yellow Card reports for COVID-19 vaccines used in pregnancy. These reports have been reviewed by the independent experts of the CHM’s Medicines for Women’s Health Expert Advisory Group (MWHEAG). Pregnant women have the same risk of getting COVID-19 as non-pregnant women, but they may be at an increased risk of becoming severely ill, particularly if they become infected in the third trimester or if they also have underlying medical problems, compared to non-pregnant women. The current advice of the Joint Committee on Vaccination and Immunisation (JCVI) is that the COVID-19 vaccines, including booster doses, should be offered to those who are pregnant as a clinical risk group in the COVID-19 vaccination programme and can be given at any stage in pregnancy. Pregnant women have reported similar suspected reactions to the original vaccines as people who are not pregnant. The COVID-19 vaccines do not contain organisms that can multiply in the body, so they cannot infect an unborn baby in the womb. There is no pattern from Yellow Card reports or published studies [footnote 2] [footnote 3] [footnote 4] [footnote 5] [footnote 6] [footnote 7]) to suggest that any of the original COVID-19 vaccines used in the UK, or any reactions to these vaccines, increase the risk of miscarriage, stillbirths, congenital anomalies or birth complications. The previous summary of COVID-19 Yellow Card reporting provides full details of safety in pregnancy for monovalent vaccines used in the previous primary and initial booster campaign.